Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

Repisalud
Publicación Artículo científico (JournalArticle)

Role of palmitoylation on the neuronal glycine transporter GlyT2.

  • Felipe, R
  • Sarmiento-Jiménez, J
  • Camafeita, E
  • Vázquez, J
  • López-Corcuera, B
The neuronal glycine transporter GlyT2 removes glycine from the synaptic cleft through active Na, Cl, and glycine cotransport contributing to the termination of the glycinergic signal as well as supplying substrate to the presynaptic terminal for the maintenance of the neurotransmitter content in synaptic vesicles. Patients with mutations in the human GlyT2 gene (SLC6A5), develop hyperekplexia or startle disease (OMIM 149400), characterized by hypertonia and exaggerated startle responses to trivial stimuli that may have lethal consequences in the neonates as a result of apnea episodes. Post-translational modifications in cysteine residues of GlyT2 are an aspect of structural interest we analyzed. Our study is compatible with a reversible and short-lived S-acylation in spinal cord membranes, detectable by biochemical and proteomics methods (acyl-Rac binding and IP-ABE) confirmed with positive and negative controls (palmitoylated and non-palmitoylated proteins). According to a short-lived modification, direct labeling using click chemistry was faint but mostly consistent. We have analyzed the physiological properties of a GlyT2 mutant lacking the cysteines with high prediction of palmitoylation and the mutant is less prone to be included in lipid rafts, an effect also observed upon treatment with the palmitoylation inhibitor 2-bromopalmitate. This work demonstrates there are determinants of lipid raft inclusion associated with the GlyT2 mutated cysteines, which are presumably modified by palmitoylation.
Repisalud
Publicación Artículo científico (JournalArticle)

Deciphering the landscape of post-translational modifications in the centrosome upon T cell activation.

  • Lozano-Prieto, Marta
  • Jorge, Inmaculada
  • Camafeita, Emilio
  • Devesa, Cristina A
  • Barrero-Rodríguez, Rafael
  • Calvo, Enrique
  • Laguillo-Gómez, Andrea
  • Pertusa, Clara
  • Martin-Cofreces, Noa B
  • Vázquez, Jesús
  • Sánchez-Madrid, Francisco
The shift from quiescent to effector T cells (TC) is controlled at the translational level. Post-translational modifications (PTMs) are key factors in the diversification of protein function. Advancements in mass spectrometry-based proteomics enable proteome-wide, hypothesis-free quantitative PTM analysis. Current research highlights the centrosome role in TC activation. Here the diversity of PTMs in the TC centrosome is studied by analyzing centrosome-enriched fractions from human resting and activated T lymphoblasts. Our results show that oxidative modifications predominate in this organelle, with tryptophan as the most frequently oxidized residue. These PTMs are enriched in proteins involved in translation, vesicular trafficking, cytoskeleton organization, among others. We also demonstrate the existence of PTM changes on specific protein regions during TC activation in Myh9 (hyperoxidized), and Gzma (hypoxidized). These hyper- or hypoxidized proteins display distinct functional distributions. Our study provides the first comprehensive PTM mapping of the TC centrosome, underscoring the PTM regulatory role in TC activation.
Repisalud
Publicación Artículo científico (JournalArticle)

Arabidopsis INHIBITOR OF GROWTH 2 promotes flowering by regulating NuA4-dependent H4 acetylation levels at FT and SOC1.

  • Barrero-Gil, Javier
  • Mouriz, Alfonso
  • Piqueras, Raquel
  • Tian, Yingnan
  • López, Juan A
  • Vázquez, Jesús
  • Crevillén, Pedro
  • Jarillo, José A
  • Piñeiro, Manuel
INHIBITOR OF GROWTH (ING) proteins are chromatin readers that bind trimethylated histone H3 lysine (K) 4 (H3K4me3) marks and associate with either histone acetyltransferase or deacetylase complexes to activate or repress gene transcription, respectively. In plants, there are two types of ING proteins, namely ING1 and ING2. Here, we report that Arabidopsis thaliana ING2 associates with multiple subunits of the histone H4 acetyltransferase complex NuA4, controls genome-wide levels of histone H4 acetylation (H4ac), and regulates different developmental processes, including the initiation of flowering. Our data indicate that ING2 biological functions are largely independent of ING1 activity. We find that ING2 is recruited to the chromatin of key floral integrators, such as FT and SOC1, and is required for their timely activation by modulating histone H4ac levels at these loci. Our observations reveal a genetic interaction between ING2 and genes encoding relevant proteins for H3K4me3 or H2A.Z deposition, suggesting that ING2 might represent a hub for potential crosstalk between histone H4ac and these histone modifications/variants.
Repisalud
Publicación Artículo científico (JournalArticle)

Atherosclerotic disease activity is associated with glycolytic enzyme expression across multiple cell types and is trackable by FDG-PET.

  • Nogales, Paula
  • Velasco, Carlos
  • González-Cintado, Leticia
  • Sharysh, Diana
  • Mota-Cobián, Adriana
  • Izquierdo-Serrano, Raúl
  • Torroja, Carlos
  • Del Rio-Aledo, David
  • Morales-Cano, Daniel
  • Mota, Rubén A
  • Benguría, Alberto
  • Dopazo, Ana
  • Sánchez-Cabo, Fátima
  • Vázquez, Jesús
  • España, Samuel
  • Carramolino, Laura
  • Mateo, Jesús
  • Bentzon, Jacob F
Positron emission tomography (PET) imaging with the radiolabeled glucose analog fluorodeoxyglucose (FDG) is used to monitor atherosclerosis in clinical trials, but there is uncertainty regarding the plaque cell types that accumulate FDG and how uptake is regulated. The long-standing view that FDG is mainly taken up by macrophages is at odds with human and experimental data, and the impact of disease activity on FDG uptake has not been examined directly. To analyze the ability of FDG-PET to monitor disease activity, we developed a model of plaque regression in minipigs with hepatic overexpression of a gain-of-function mutant of (). Atherosclerosis was induced through 12 months of high-fat feeding in the porcine model. Disease activity was then lowered for 3 months by reducing plasma cholesterol with a low-fat diet alone or in combination with the microsomal transfer protein (MTP) inhibitor BMS-212122. Plaque regression in advanced lesions of the abdominal aorta was evident from reduced lipid content, reduced necrotic core size, and partial resolution of plaque inflammation and was accompanied by a decline in FDG-PET signal. Single-cell gene expression profiling revealed that plaque regression involved substantial down-regulation of genes encoding glycolytic enzymes in smooth muscle cells (SMCs), macrophages, and lymphocytes, which was corroborated by analysis of the plaque cellular proteome. These findings in a large-animal model suggest that FDG-PET can monitor atherosclerosis because of a close association between disease activity and glycolytic enzyme expression in all of the major plaque cell types.
Repisalud
Publicación Artículo científico (JournalArticle)

Phosphatase-independent activity of smooth-muscle calcineurin orchestrates a gene expression program leading to hypertension.

  • Yunes-Leites, Paula Sofía
  • Sun, Yilin
  • Martínez-Martínez, Sara
  • Alfayate, Álvaro
  • Toral, Marta
  • Méndez-Olivares, María José
  • Colmenar, Ángel
  • Torralbo, Ana Isabel
  • López-Maderuelo, Dolores
  • Mateos-García, Sergio
  • Cornfield, David N
  • Vázquez, Jesús
  • Redondo, Juan Miguel
  • Campanero, Miguel R
Angiotensin-II (Ang-II) drives pathological vascular wall remodeling in hypertension and abdominal aortic aneurysm (AAA) through mechanisms that are not completely understood. Previous studies showed that the phosphatase activity of calcineurin (Cn) mediates Ang-II-induced AAA, but the cell type involved in the action of Cn in AAA formation remained unknown. Here, by employing newly created smooth muscle cell (SMC)-specific and endothelial cell (EC)-specific Cn-deficient mice (SM-Cn-/- and EC-Cn-/- mice), we show that Cn expressed in SMCs, but not ECs, was required for Ang-II-induced AAA. Unexpectedly, SMC Cn also played a structural role in the early onset and maintenance of Ang-II-induced hypertension, independently of its known phosphatase activity. Among the signaling pathways activated by Ang-II, Cn signaling is essential in SMCs, as nearly 90% of the genes regulated by Ang-II in the aorta required Cn expression in SMCs. Cn orchestrated, independently of its enzymatic activity, the induction by Ang-II of a transcriptional program closely related to SMC contractility and hypertension. Cn deletion in SMCs, but not its pharmacological inhibition, impaired the regulation of arterial contractility. Among the genes whose regulation by Ang-II required Cn expression but not its phosphatase activity, we discovered that Serpine1 was critical for Ang-II-induced hypertension. Indeed, pharmacological inhibition of PAI-1, the protein encoded by Serpine1, impaired SMCs contractility and readily regressed hypertension. Mechanistically, Serpine1 induction was mediated by Smad2 activation via the structural role of Cn. These findings uncover an unexpected role for Cn in vascular pathophysiology and highlight PAI-1 as a potential therapeutic target for hypertension.
Repisalud
Publicación Artículo científico (JournalArticle)

A Multiplexed Quantitative Proteomics Approach to the Human Plasma Protein Signature.

  • Núñez, Estefanía
  • Gómez-Serrano, María
  • Calvo, Enrique
  • Bonzon-Kulichenko, Elena
  • Trevisan-Herraz, Marco
  • Rodríguez, José Manuel
  • García-Marqués, Fernando
  • Magni, Ricardo
  • Lara-Pezzi, Enrique
  • Martín-Ventura, José Luis
  • Camafeita, Emilio
  • Vázquez, Jesús
Despite the plasma proteome being able to provide a unique insight into the health and disease status of individuals, holding singular promise as a source of protein biomarkers that could be pivotal in the context of personalized medicine, only around 100 proteins covering a few human conditions have been approved as biomarkers by the US Food and Drug Administration (FDA) so far. Mass spectrometry (MS) currently has enormous potential for high-throughput analysis in clinical research; however, plasma proteomics remains challenging mainly due to the wide dynamic range of plasma protein abundances and the time-consuming procedures required. We applied a new MS-based multiplexed proteomics workflow to quantitate proteins, encompassing 67 FDA-approved biomarkers, in >1300 human plasma samples from a clinical cohort. Our results indicate that this workflow is suitable for large-scale clinical studies, showing good accuracy and reproducibility (coefficient of variation (CV) < 20 for 90% of the proteins). Furthermore, we identified plasma signature proteins (stable in time on an individual basis), stable proteins (exhibiting low biological variability and high temporal stability), and highly variable proteins (with low temporal stability) that can be used for personalized health monitoring and medicine.
Repisalud
Publicación Artículo científico (JournalArticle)

In-gel protein digestion using acidic methanol produces a highly selective methylation of glutamic acid residues.

  • Lozano-Prieto, Marta
  • Camafeita, Emilio
  • Jorge, Inmaculada
  • Laguillo-Gómez, Andrea
  • Barrero-Rodríguez, Rafael
  • Devesa, Cristina A
  • Pertusa, Clara
  • Calvo, Enrique
  • Sánchez-Madrid, Francisco
  • Vázquez, Jesús
  • Martin-Cofreces, Noa B
Mass-tolerant open search methods allow the high-throughput analysis of modified peptides by mass spectrometry. These techniques have paved the way to unbiased analysis of post-translational modifications in biological contexts, as well as of chemical modifications produced during the manipulation of protein samples. In this work, we have analyzed in-depth a wide variety of samples of different biological origin, including cells, extracellular vesicles, secretomes, centrosomes and tissue preparations, using Comet-ReCom, a recently improved version of the open search engine Comet-PTM. Our results demonstrate that glutamic acid residues undergo intensive methyl esterification when protein digestion is performed using in-gel techniques, but not using gel-free approaches. This effect was highly specific to Glu and was not found for other methylable residues such as Asp.
Repisalud
Publicación Artículo científico (JournalArticle)

Lack of p38 activation in T cells increases IL-35 and protects against obesity by promoting thermogenesis.

  • Nikolic, Ivana
  • Ruiz-Garrido, Irene
  • Crespo, María
  • Romero-Becerra, Rafael
  • Leiva-Vega, Luis
  • Mora, Alfonso
  • León, Marta
  • Rodríguez, Elena
  • Leiva, Magdalena
  • Plata-Gómez, Ana Belén
  • Alvarez Flores, Maria Beatriz
  • Torres, Jorge L
  • Hernández-Cosido, Lourdes
  • López, Juan Antonio
  • Vázquez, Jesús
  • Efeyan, Alejo
  • Martin, Pilar
  • Marcos, Miguel
  • Sabio, Guadalupe
Obesity is characterized by low-grade inflammation, energy imbalance and impaired thermogenesis. The role of regulatory T cells (Treg) in inflammation-mediated maladaptive thermogenesis is not well established. Here, we find that the p38 pathway is a key regulator of T cell-mediated adipose tissue (AT) inflammation and browning. Mice with T cells specifically lacking the p38 activators MKK3/6 are protected against diet-induced obesity, leading to an improved metabolic profile, increased browning, and enhanced thermogenesis. We identify IL-35 as a driver of adipocyte thermogenic program through the ATF2/UCP1/FGF21 pathway. IL-35 limits CD8 T cell infiltration and inflammation in AT. Interestingly, we find that IL-35 levels are reduced in visceral fat from obese patients. Mechanistically, we demonstrate that p38 controls the expression of IL-35 in human and mouse Treg cells through mTOR pathway activation. Our findings highlight p38 signaling as a molecular orchestrator of AT T cell accumulation and function.
Repisalud
Publicación Artículo científico (JournalArticle)

A New GlyT2 Variant Associated with Hyperekplexia.

  • Sarmiento-Jiménez, Jorge
  • Felipe, Raquel
  • Núñez, Enrique
  • Ferrando-Muñoz, Alejandro
  • Benito-Muñoz, Cristina
  • Gago, Federico
  • Vázquez, Jesús
  • Camafeita, Emilio
  • Clement, Emma
  • Wilson, Brian
  • López-Corcuera, Beatriz
Hyperekplexia (OMIM 149400), a sensorimotor syndrome of perinatal clinical relevance, causes newborns to display an energic startle reflex in response to certain trivial stimuli. This condition can be lethal due to apnea episodes. The disease is caused by a blockade of glycinergic neurotransmission. Glycinergic interneurons preserve their identity by the activity of the surface glycine transporter GlyT2, which supplies glycine to presynaptic terminals to maintain glycine content in synaptic vesicles. Loss-of-function mutations in the GlyT2 gene () cause a presynaptic form of human hyperekplexia. Here, we describe a new GlyT2 variant found in an infantile patient diagnosed with hyperekplexia. A missense mutation in the open reading frame of the GlyT2 gene inherited in homozygosity caused the substitution G449E in a residue highly conserved across the phylogenetic scale. The sequences of the glycine receptor genes and did not show abnormalities. We expressed the recombinant GlyT2 variant in heterologous cells and analyzed its pathogenic mechanism. The transporter was totally inactive, behaving as a bona fide loss-of-function mutant. Furthermore, the mutation promoted the abnormal insertion of the protein into the membrane, leading to its large incorporation into lipid rafts. However, there was no apparent alteration of wild-type trafficking upon mutant coexpression, as the mutant was prematurely degraded from the endoplasmic reticulum. Rescue with chemical chaperones was not possible for this mutant. Proteomics demonstrated that the expression of the mutant induced the unfolded protein response and interfered with raft-dependent processes. Therefore, the new variant causes a loss of function regarding GlyT2 activity but a gain of function as a cell proteostasis disturber.
Repisalud
Publicación Artículo científico (JournalArticle)

An audit of the PeptideAtlas database uncovers evidence for repurposed pseudogenes and co-opted retroviral ORFs.

  • Rodriguez, Jose Manuel
  • Maquedano, Miguel
  • Cerdán-Vélez, Daniel
  • Laguillo-Gómez, Andrea
  • Calvo, Enrique
  • Abascal, Federico
  • Vázquez, Jesús
  • Tress, Michael L
The human genome has been the subject of scrutiny for more than two decades, yet new protein coding genes are still being uncovered. Recently ribosome profiling experiments have provided evidence for the translation of thousands of novel open reading frames (ORFs). To determine how many of these novel ORFs have peptide support, we carried out an in-depth investigation of an entire mass spectrometry proteomics database. We analysed the peptides housed in the human build of the PeptideAtlas database and identified reliable evidence for 35 potential coding genes not annotated in the Ensembl/GENCODE reference gene set. Evidence from complementary sources confirmed that 16 were almost certainly coding genes, but we believe that at least 14 are most likely to be undergoing aberrant translation. These 14 genes had reading frames that were not preserved beyond human and their peptides were restricted to cancers or cell lines. Remarkably, three of the sixteen likely coding genes were derived from endogenous retroviral ORFs and were expressed only in placenta. All three had evidence of purifying selection. Retroviral ORFs (syncytins) with distinct origins are expressed in almost all mammalian placentae and these results suggest that co-opted ORFs may also play an important role in placental development. Our analysis shows that proteomics data can be used in conjunction with evolutionary evidence to confirm the existence of new coding genes. The evidence suggests that both testis and placenta are the tissues most likely to express still to be identified coding genes, and that there may be other transposon-derived ORF that have been co-opted as coding genes. The strong evidence for the translation of regions under dysregulated conditions has important implications for the annotation of coding genes and in the analysis of cancer and other degenerative diseases.The online version contains supplementary material available at 10.1186/s12864-025-12238-w.
Repisalud
Publicación Artículo científico (JournalArticle)

Cerebrospinal fluid lipoprotein-mediated cholesterol delivery to neurons is impaired in Alzheimer's disease and involves APOE4.

  • Borràs, Carla
  • Canyelles, Marina
  • Santos, David
  • Rotllan, Noemí
  • Núñez, Estefanía
  • Vázquez, Jesús
  • Maspoch, Daniel
  • Cano-Sarabia, Mary
  • Zhao, Qi
  • Carmona-Iragui, Maria
  • Sirisi, Sònia
  • Lleó, Alberto
  • Fortea, Juan
  • Alcolea, Daniel
  • Blanco-Vaca, Francisco
  • Escolà-Gil, Joan Carles
  • Tondo, Mireia
In the central nervous system, apolipoprotein (APO)E-containing lipoprotein particles mediate the transport of glial-derived cholesterol to neurons, which is essential for neuronal membrane remodeling and maintenance of the myelin sheath. We aimed to examine cholesterol transport via lipoprotein particles in cerebrospinal fluid (CSF) of Alzheimer's disease (AD) patients compared to control individuals. Additionally, we explored the ability of reconstituted HDL containing different APOE isoforms to regulate cholesterol transport. We evaluated the capacity of CSF lipoprotein particles to facilitate radiolabeled unesterified cholesterol efflux from A172 human glioblastoma astrocytes and to deliver cholesterol to SH-SY5Y human neuronal cells. The CSF lipoprotein proteome was analyzed by LC-MS/MS. Reconstituted HDL nanoparticles were prepared by combining phospholipids and cholesterol with human APOE3 or APOE4, followed by radiolabeling with unesterified cholesterol. Our results showed that cholesterol efflux from astrocytes to CSF were similar between AD patients and controls, both under baseline conditions and after activation of ABCA1 and ABCG1. However, CSF lipoprotein-mediated neuronal cholesterol uptake was significantly reduced in the AD group. LC-MS/MS analysis identified 239 proteins associated with CSF lipoproteins in both groups, with no major alterations in proteins linked to cholesterol metabolism. However, 27 proteins involved in noncholesterol-related processes were differentially expressed. Notably, synthetic reconstituted HDL particles containing APOE4 exhibited reduced capacity to deliver cholesterol to neurons compared to those with APOE3. These findings indicate that CSF lipoproteins from patients with AD demonstrate impaired cholesterol delivery to neurons. Our study highlights APOE4 as a critical contributor to abnormal neuronal cholesterol uptake in AD pathophysiology.